Accordingly, dysregulation of the SCAP-SREBP pathway has been reported to be closely associated with an increased risk of obesity, hypercholesterolemia, and cardiovascular disease. The gene discussed is SCAP; the disease is obesity due to melanocortin 4 receptor deficiency.